Do you have the same question? Follow this Question
Oct 23, 2025 - 11:14 AM
We’ve provided several answers to questions related to Ibsrela (Tenapanor) , see some other helpful Q&A related to this product.
Question: What is tenapanor used to treat?
Answer: Tenapanor is a medication used to treat adults with irritable bowel syndrome with constipation (IBS-C). It works by reducing the absorption of sodium in the intestines, which helps increase bowel movements and relieve constipation.
Question: Was Ibsrela discontinued?
Answer: As of June 2024, Ibsrela (tenapanor) has not been discontinued and is still available by prescription in the United States. There have been no official announcements from the manufacturer or regulatory agencies about its discontinuation.
Question: What is IBSrela used to treat?
Answer: IBSrela is a medication used to treat irritable bowel syndrome with constipation (IBS-C) in adults. It helps relieve symptoms such as abdominal pain and constipation by increasing bowel movements.
Question: What is the mechanism of action of this medication?
Answer: The medication works by blocking a protein in the gut that absorbs salt, which increases water in the intestines and helps relieve constipation and pain. This targeted mechanism is valuable because it directly addresses the symptoms of IBS-C.
Question: What condition is this medication used to treat?
Answer: It is used to treat irritable bowel syndrome with constipation (IBS-C) in adults. Treating IBS-C can significantly improve quality of life by reducing pain and improving bowel function.
Question: Is this medication approved by the US FDA?
Answer: Yes, it is licensed by the US FDA. FDA approval signifies that the medication has been rigorously tested for safety and efficacy.
Question: What is the brand name for this medication?
Answer: The brand name is Ibsrela. Brand names help patients and providers recognize and differentiate medications.
Question: What is the KEGG code for this medication?
Answer: The KEGG code is D10801. KEGG (Kyoto Encyclopedia of Genes and Genomes) code is used in bioinformatics for linking chemical substances to biological systems.
Question: What is the DrugBank ID for this medication?
Answer: The DrugBank ID is DB12047. DrugBank is an online database that provides detailed drug data for research and clinical use.
Question: What is the ATC code for this medication?
Answer: The ATC code is A06AX07. ATC (Anatomical Therapeutic Chemical) code helps classify drugs and is valuable for pharmacists and clinicians for identification and reimbursement.
Question: What is the ChEBI code for this medication?
Answer: The ChEBI code is 145514. ChEBI is a database for chemical entities of biological interest, which is useful for researchers and healthcare professionals.
Question: What is the PubChem CID for this medication?
Answer: The PubChem CID is 25035845. PubChem CID is a unique identifier used in scientific databases for easy reference and research.
Question: What is the MedlinePlus code for this medication?
Answer: The MedlinePlus code is a619039. MedlinePlus is a trusted source for patient-friendly drug information.
Question: What is the protein binding rate of this medication?
Answer: The protein binding is greater than 99%. High protein binding can impact how the drug is distributed in the body and may reduce the risk of drug interactions due to limited systemic exposure.
Question: How should the tablets be taken?
Answer: The tablets should be swallowed whole without crushing, chewing, or breaking them. Swallowing the tablet whole ensures the medication is released properly in the digestive tract for optimal effectiveness.
Question: What is the usual dosing schedule?
Answer: It is typically taken once before breakfast and once before dinner. This dosing schedule helps to maintain steady therapeutic levels and improve symptom control throughout the day.
Question: What is the recommended route of administration?
Answer: The medication is taken orally. Oral administration is convenient and non-invasive, making it easier for patients to adhere to their treatment.
Question: What is the legal status of this medication?
Answer: It is available by prescription only (Rx). Prescription-only status ensures that the medication is used under medical supervision for safety and efficacy.
Question: What is the bioavailability of this medication?
Answer: The bioavailability is minimal, meaning there is negligible systemic absorption. This is valuable because it reduces the risk of systemic side effects and drug interactions.
Question: What is the chemical name of the active ingredient?
Answer: The chemical name is 2-[[[2-[(2S)-2-[[(1R)-1-[5-(aminosulfonyl)-2-fluorophenyl]-1-hydroxy-2-(methyla
mino)ethyl]amino]-2-phenylacetyl]amino]acetyl]amino]methyl]-4-[4-(trifluorometh
yl)phenyl]methyl]phenyl]butanoic acid. Knowing the chemical name helps healthcare professionals identify the drug's exact composition for safety and compatibility.
Question: What is the formula of the active ingredient?
Answer: The formula of Tenapanor is C50H66F9N9O10S2. This chemical structure is responsible for the medication's unique mechanism of action, making it effective for its intended use.
Question: What is the strength of each tablet?
Answer: Each tablet contains 50 mg of Tenapanor. This standardized dosage ensures consistent therapeutic effects and makes it easier for patients to follow their prescribed regimen.
Question: What is the active ingredient in this medication?
Answer: The active ingredient is Tenapanor. Tenapanor is specifically designed to treat irritable bowel syndrome with constipation (IBS-C) by acting locally in the gut, which is valuable for targeted treatment and minimizing systemic side effects.
